RxDoctor Payments Data

Laurel Berry, MD

Gynecologic Oncology · Winston Salem, NCNPI 1093079634

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (35.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 75.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,344 and has fallen 77.4% since, to $304 in 2025.

$3,412in general payments, 2019–2025

Across 23 payments — averaging $148.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Eisai Inc.$219
  • AstraZeneca$211
  • Stryker$198
  • Genmab U.S., Inc.$118
  • Merck$79
  • plus $14 from 1 others

What the payments were for

  • Travel & lodging$1,17534%
  • Food & beverage$1,22336%
  • Education$1,01430%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical14$2,572
Eisai Inc.2$219
AstraZeneca2$211
Stryker2$198
Genmab U.S., Inc.1$118
Merck1$79
Tesaro, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,412 in reported general payments places this provider in the 65th percentile of 52 gynecologic oncology providers in North Carolina.

See all gynecologic oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$33,980
Medicare patients
55
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$6,225

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →